Articles with the keyword: 
Increased Mortality after Dronedarone Therapy for Severe Heart Failure
kavin submitted, created time 1 year 8 months (content.nejm.org)
Background: Dronedarone is a novel antiarrhythmic drug with electrophysiological properties that are similar to those of amiodarone, but it does not contain iodine and thus does not cause iodine-related adverse reactions. Therefore, it may be of value in the treatment of patients with heart failure.
Methods: In a multicenter study with a double-blind design, we planned to randomly assign 1000 patients who were hospitalized with symptomatic heart failure and severe left ventricular systolic dysfunction to receive 400 mg of dronedarone twice a day or placebo 
Treating chronic pain without side-effects?
Sue Wu submitted, created time 2 years 2 months (www.nature.com)
A drug has been found that treats chronic pain in mice, without the usual painkiller side effects of sedation, addiction or developing tolerance.
Building a New Heart From Old Tissue
Eric wu submitted, created time 2 years 2 months (sciencenow.sciencemag.org)
Approximately 3000 patients in the United States are on the waiting list for a heart transplant, but only about 2000 donor organs become available each year.
This article put forward a new method to solve the life-and-death problem.It includes two pivotal factors:The first one is that we need to find an appropriate stem cell that can give rise to heart tissue;The second one is that the cells require a framework, or scaffolding, to grow on.
Do you think it is feasible to resolve the difficult medical problem?
Trimetazidine improves endothelial dysfunction in chronic heart failure: an antioxidant effect
amanda submitted, created time 2 years 10 months (eurheartj.oxfordjournals.org)
"TMZ improves the ED-relaxation in patients with ischaemic cardiomyopathy. The antioxidant properties of TMZ may play a role. "
badboy submitted, created time 2 years 11 months (eurheartj.oxfordjournals.org)
" S-SMase is upregulated in CHF, independent of aetiology. The association of S-SMase with clinical status, tissue amount, functional capacity of skeletal muscle tissue, and vasodilator capacity suggests that S-SMase-mediated signalling may contribute to regulatory processes of CHF pathophysiology. "
\ 1
\ 
abuse@discover8.com
Darkfrog
angelfish
jane2007
DanyC
GenScript provides custom solutions to affinity maturation, antibody humanization, and stable cell line development for antibody drug development.
www.genscript.com
Molecular Biology Services
GenScript is the largest gene synthesis service supplier in the U.S., providing economical molecular biology outsourcing.
www.genscript.com